When's Best Time for Your COVID Booster? That May Depend on You
By Dennis Thompson HealthDay Reporter
MONDAY, Dec. 2, 2024 -- Folks might want to try timing their COVID-19 booster vaccine to coincide with a period of increased transmission in their area, a new study suggests.
Doing so can improve protection against COVID infection as much as fourfold compared to getting the jab when the coronavirus isn’t spreading as much, researchers report in the journal Clinical Infectious Diseases.
“Timing is everything when it comes to COVID-19 boosters,” lead researcher Jeffrey Townsend, a professor of biostatistics at the Yale School of Public Health, said in a news release.
“Our research shows that receiving your booster shot at the right time can make a significant difference in your protection against infection,” he said. “By tailoring booster schedules to local COVID-19 patterns, we can help ensure people are best protected when they need it most.”
Results show that receiving a booster in September or October provides three to four times more protection against infection in the U.S., compared to shots given later in the year.
For example, New Yorkers can get the best protection by getting their booster on Sept. 15, the study found. Waiting until January reduces its effectiveness by 3.6-fold.
Ideally, booster shots should precede peak COVID periods by just under three months, the study found. That gives the shot a chance to maximize protection just as the virus starts to circulate, researchers said.
Delaying booster shots also might be best for people who experience a breakthrough COVID infection despite being vaccinated, researchers added. This is especially true if their infection occurs late in the year, at the height of the cold and flu season.
If a breakthrough infection occurs around the time someone has a scheduled booster, they might want to consider delaying it by several months to optimize their immunity, researchers said.
Researchers noted that these findings are particularly important for people at high risk for severe COVID, including the elderly and patients with compromised immune systems.
Sources
- Yale School of Public Health, news release, Nov. 26, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Further Support and Information on COVID-19
Read this next
FDA Approves Prefilled Syringe Presentation for Shingles Vaccine
MONDAY, July 21, 2025 -- The U.S. Food and Drug Administration has approved a prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted) for the...
Few Babies Getting RSV Antibody Shot, Beyfortus, Study Says
THURSDAY, July 17, 2025 — A new antibody shot that protects babies against RSV infection could be struggling to gain traction, researchers report. Only about a third (35%)...
WHO, UNICEF Say More Than 14 Million Infants Worldwide Remain Unvaccinated
WEDNESDAY, July 16, 2025 -- Data released this week by the World Health Organization and UNICEF indicate modest gains in childhood vaccination rates, but globally, more than 14...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.